Parliamentary panel for framing price control regime for COVID medicines, medical devices https://ift.tt/AHrKkx7

Citing the example of non-scheduled drug Remdesivir the price for which varied up to Rs 5,400 per vial but reduced to less than Rs 3,500 per vial voluntarily by major manufacturers and marketers after "proactive" government intervention, the panel suggested effective price control of non-scheduled COVID-19 related medicines and medical devices.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/EfTx5nj